Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- B2171 Imatinib (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Protein-tyrosine kinase inhibitor
- B2302 ZM 323881 HClSummary: selective VEGFR2 inhibitor
- B1494 Tyrphostin 9Summary: Selective EGFR/PDGFR inhibitor
- B1301 A 419259 trihydrochlorideSummary: LCK inhibitor, orally available
- B1104 AZD-92911 CitationTarget: EGFRSummary: Mutated forms EGFR inhibitor
- B1105 AZD-9291 mesylateSummary: third generation EGFRm inhibitor, oral and irreversible
- B2297 GW4417561 CitationTarget: Trk ReceptorsSummary: TrkA inhibitor,potent and selective
- B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
- B1543 Mubritinib (TAK 165)Target: ErbBSummary: Potent inhibitor of HER2/ErbB2
- B1523 PF-5732281 CitationSummary: ATP-competitive FAK inhibitor